Viewing nowNatusil Tablets (Terbinafine Hydrochloride)
Terbinafine Hydrochloride 140.625mg
Tablet · Prescription medication
Jinyang Pharmaceutical Co., Ltd.

MFDS item code 201706355 · Approved 2017.07.31 · Insurance code 650303680
Treatment of onychomycosis and cutaneous fungal infections (such as tinea pedis and tinea corporis)
This medication is used to treat dermatophyte infections of the skin such as athlete's foot, ringworm, and tinea capitis in adults. It is also used for treating onychomycosis (fungal infection of the nails) and tinea capitis in children.
Administer terbinafine 125 mg twice daily or 250 mg once daily. The duration of treatment according to the condition is as follows. 1) Dermatophytosis Tinea pedis (interdigital, plantar/moccasin type): 2~6 weeks Tinea corporis: 2∼4 weeks Tinea cruris: 2~4 weeks 2) Onychomycosis Treatment is usually given for 6 weeks~3 months. For infection of a fingernail or a relatively small toenail, or in younger patients, the treatment period may be shortened to 3 months or less. Three months is usually sufficient to treat toenail infections, but treatment may take 6 months or longer in some patients. The treatment period may be longer in patients with slow nail growth. In patients with creatinine clearance below 50 mL/min, reduce the daily dose by 1/2.
Administer to children 2 years of age or older. As there is no experience with administration in children under 2 years of age, use is not recommended. Tinea capitis: 4 weeks 1) Body weight under 20 kg (under 5 years): Administer 62.5 mg once daily. 2) Body weight 20~40 kg (5~12 years): Administer 125 mg once daily. 3) Body weight over 40 kg (over 12 years): Administer 250 mg once daily.
This medication should not be used in patients with chronic liver disease or active liver disease. It is important to check for a history of liver disease before taking this medication. Regular liver function tests should be performed before and during treatment due to the risk of liver dysfunction. If liver function test values rise, the use of this medication should be stopped immediately. If symptoms such as nausea, loss of appetite, fatigue, vomiting, upper abdominal pain, jaundice, dark urine, or diarrhea occur during treatment, inform a doctor immediately. This medication can cause serious liver damage, such as liver failure, so it should be stopped immediately if any symptoms of liver damage occur. Patients with a history of allergic reactions to this medication, those with liver disease, blood disorders, severe renal failure, breastfeeding women, and children under 2 years of age should not take it. Patients with lactose intolerance should avoid this medication due to the lactose component. Caution is advised for elderly patients, those with reduced kidney function, and low-weight children. This medication can rarely cause serious skin reactions, so discontinue if any rashes or unusual symptoms occur. Dizziness may occur while driving or operating machinery, so caution is needed. Since this medication may interact with other drugs, inform your doctor or pharmacist of any other medications you are taking. Women who are pregnant or may become pregnant should carefully consider the risks and benefits of taking this medication, and breastfeeding should be discontinued while taking it. Overdosage may cause headache, nausea, abdominal pain, and dizziness, requiring immediate medical attention. Store this medication out of the reach of children and avoid direct sunlight, keeping it at room temperature.
Liver failure, hepatitis, cholestasis, jaundice, rash, skin itching, fever, nausea, vomiting, loss of appetite, malaise, elevated γ-GTP, elevated AST/ALT, elevated LDH, elevated ALP, neutropenia, pancytopenia, agranulocytosis, thrombocytopenia, pharyngitis, fever, lymphadenopathy, purpura, subcutaneous hemorrhage, leukopenia, anemia, rash, itching, photosensitivity reaction, mucocutaneous syndrome, Stevens-Johnson syndrome, toxic epidermal necrolysis, acute generalized exanthematous pustulosis, erythema multiforme, toxic skin rash, exfoliative dermatitis, blisters, psoriatic rash, exacerbation of psoriasis, alopecia, musculoskeletal reaction, arthralgia, myalgia, weakness, elevated CPK, elevated serum myoglobin, elevated urine myoglobin, hypotension, dyspnea, chest tightness, urticaria, erythema, facial edema, lymphangitis, abdominal distension, decreased appetite, dyspepsia, mild abdominal pain, diarrhea, discomfort in the upper abdomen, thirst, glossitis, depression, anxiety, headache, taste disturbance, dizziness, drowsiness, sensory disturbances, sensory reduction, decreased concentration, insomnia, elevated BUN, oliguria, visual disturbances, tinnitus, anaphylactic reaction, angioedema, systemic lupus erythematosus, elevated total cholesterol, elevated triglyceride levels, malaise, tongue discoloration, palpitations, edema, menstrual irregularities, paralysis, systemic disorders, fever, fatigue, weight loss, anaphylactic reaction, serum sickness-like reaction, blurred vision, decreased vision, hearing loss, auditory impairment, vasculitis, permanent loss of smell, anosmia, hyposmia, drug rash with eosinophilia and systemic symptoms, pancreatitis, rhabdomyolysis, influenza-like illness, elevated serum creatine phosphokinase, headache, nausea, upper abdominal pain, dizziness
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent air or moisture from entering, at a temperature between 1 degree and 30 degrees Celsius. Proper storage will help maintain the effectiveness of the medication.
White to almost colorless round tablets
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowTerbinafine Hydrochloride 140.625mg
Tablet · Prescription medication
Jinyang Pharmaceutical Co., Ltd.
Terbinafine Hydrochloride 10mg
Cream · OTC medication
GP Therapeutics Korea Co., Ltd.
Terbinafine Hydrochloride 10mg
Cream · OTC medication
Korea Hutex Pharmaceutical Co., Ltd.
Terbinafine Hydrochloride 10mg
Cream · OTC medication
Anguk Pharmaceutical Co., Ltd.
Terbinafine Hydrochloride 10mg
Cream · OTC medication
Medica Korea Co., Ltd.
Terbinafine Hydrochloride 10mg
Cream · OTC medication
Gyeongnam Pharmaceutical Co., Ltd.
Terbinafine Hydrochloride 10mg
Cream · OTC medication
Daehwa Pharmaceutical Co., Ltd.
Terbinafine Hydrochloride 10mg
Cream · OTC medication
Korea Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.